Liz is a highly regarded industry leader with extensive experience leading, building and growing organizations at Fortune 100 pharmaceutical companies before moving to a biotech company. She has been recognized as one of Fortune’s Most Powerful Women and Forbes 50 over 50 among other industry awards.
Ms. Barrett has served as director and President and Chief Executive Officer of UroGen® since January 2019. Prior to UroGen, Ms. Barrett was CEO of Novartis Oncology and a member of the Novartis Executive Committee.
Prior to Novartis, Ms. Barrett served at Pfizer, Inc. in various leadership capacities, most recently as the Global President of Oncology and, before that, as President of Global Innovative Pharma for Europe, President of the Specialty Care Business Unit for North America, and Regional President of United States Oncology.
Before Pfizer, Ms. Barrett held positions at Cephalon, Inc., where she built then ran the Oncology Business Unit, and at Johnson & Johnson where she led the Oncology Franchise. She spent the first ten years of her career in the Consumer industry.
Ms. Barrett also currently serves on the board of directors of Allogene Therapeutics.
Ms. Barrett received an M.B.A. degree in marketing from Saint Joseph's University and a B.S. from the University of Louisiana.
